Effects of Dexamethasone on Nausea, Vomiting, and Inflammatory Indexes After Total Knee Arthroplasty.
Jiazheng Chen, Yizhen He, Ting Deng...
https://pubmed.ncbi.nlm.nih.gov/40803755Actively Recruiting
Led by Haseki Training and Research Hospital · Updated on 2026-05-20
270
Participants Needed
1
Research Sites
43 weeks
Total Duration
Researchers are evaluating how the timing and method of dexamethasone administration affect early recovery after primary total knee arthroplasty in adults aged 50 to 80 with knee osteoarthritis. The study focuses on comparing oral versus intravenous dexamethasone, or no dexamethasone, as given by surgeons in routine clinical care. The goal is to understand effects on pain, mobility, knee movement, inflammation, metabolic changes, opioid use, and nausea during early recovery. Participants receive dexamethasone according to their surgeon's usual protocol: either 8 mg preoperatively and 4 mg postoperatively given intravenously or orally, or no dexamethasone if not part of the routine care. All surgeries and postoperative care, including pain management and opioid use when needed, follow standard institutional procedures without any changes introduced by the study. During the early postoperative period, participants undergo regular assessments of pain using a visual analog scale every six hours for 48 hours, mobility tests daily, nausea scoring, knee range of motion, inflammation markers, blood sugar levels, and opioid consumption. Data is collected prospectively, and participants provide consent before enrollment. The study observes real-world outcomes without altering standard treatment and will analyze results to understand recovery differences.
CONDITIONS
Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery to postoperative day 2
Participants undergo total knee arthroplasty with perioperative dexamethasone administration according to the routine protocol of the operating surgeon or receive no dexamethasone. Postoperative management follows standard institutional care including multimodal analgesia and clinical assessments.
Daily visits during hospital stay including surgery day and first 2 postoperative days
Duration - Up to 2 days after surgery
Participants are monitored for early postoperative recovery including pain intensity, functional mobility, nausea and vomiting, opioid use, laboratory markers, and knee range of motion according to routine care protocols.
Daily assessments for 2 days post-surgery
Total: 1 location
1
Sultangazi Haseki Training and Research Hospital
Istanbul, Istanbul, Turkey (Türkiye), 34200
Actively Recruiting
A
Atahan Eryilmaz, Resident Physician
M
Mehmet Ersin, Associate Professor
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jiazheng Chen, Yizhen He, Ting Deng...
https://pubmed.ncbi.nlm.nih.gov/40803755Gildàsio S De Oliveira, Marcela D Almeida, Honorio T Benzon...
https://pubmed.ncbi.nlm.nih.gov/21799397Shuang Liang, Manyu Xing, Shasha Jiang...
https://pubmed.ncbi.nlm.nih.gov/35322969Bin Xu, Jun Ma, Qiang Huang...
https://pubmed.ncbi.nlm.nih.gov/28474088Timmy Chi Wing Chan, Chi Wai Cheung, Stanley Sau Ching Wong...
https://pubmed.ncbi.nlm.nih.gov/33105245